Recently, the progresses in stem cell research and somatic reprogramming techniques make it possible to obtain autologous functional cell types, such as cardiomyocytes, hepatocytes, pancreatic beta cells and neurons, for tissue repair and regeneration. Thus, the “regenerative medicine” strategy provides new solutions and new hope to cure many series diseases and degenerative diseases, such as myocardial infarction, liver failure, diabetes and Alzheimer’s diseases.
Our lab studies the mechanism of cell fate regulation and develops new techniques on cell fate reprogramming. On one hand, we will study the molecular mechanism of cell fate maintenance and reprogramming based on our recently established chemical reprogramming systems. On the other hand, we will develop new chemical reprogramming systems with clinical application potential. The major goal is to achieve in vivo regeneration of functional cell types of cardiovascular system and metabolic system, such as cardiomyocytes and hepatocytes, providing “regenerative medicine” solutions to cure cardiovascular diseases and metabolic diseases.
Post Doc.：Jun Cai PhD Email：email@example.com
Administration assitant：Dianhong Tang firstname.lastname@example.org
Room #207 Wangkezhen building，
Haidian Road #52,
Beijing, China, 100871